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Early events of B cell activation after B cell receptor
(BCR) triggering have been well characterized.
However, little is known about the steady state of
the BCR on the cell surface. Here, we simultaneously
visualize single BCR particles and components of the
membrane skeleton. We show that an ezrin- and
actin-defined network influenced steady-state BCR
diffusion by creating boundaries that restrict BCR
diffusion. We identified the intracellular domain of
Igb as important in mediating this restriction in diffu-
sion. Importantly, alteration of this network was suffi-
cient to induce robust intracellular signaling and
concomitant increase in BCR mobility. Moreover, by
using B cells deficient in key signaling molecules, we
show that this signaling was most probably initiated
by the BCR. Thus, our results suggest the membrane
skeleton plays a crucial function in controlling BCR
dynamics and thereby signaling, in a way that could
be important for understanding tonic signalingneces-
sary for B cell development and survival.
INTRODUCTION
Adaptive immune responses are initiated after B cell receptor
(BCR) recognition of specific antigen on the surface of viruses,
bacteria, or presenting cells (Batista and Harwood, 2009). In
naive B cells, the BCR is composed of either nonsignaling
membrane immunoglobulin M (IgM) or IgD to provide recognition
of extracellular antigen, in complex with a signaling transmem-
brane Iga-b heterodimer containing immunoreceptor tyrosine-
based activation motifs (ITAMs) (Reth, 1989). Engagement of
specific antigen by the BCR initiates phosphorylation of ITAM
residues and the recruitment of intracellular signaling molecules
including Vav, Bruton’s tyrosine kinase (Btk), phospholipase
C-g2 (PLCg2), and B cell linker (BLNK) (DeFranco, 1997; Kuro-
saki, 2002). This intracellular signaling cascade leads to changes
in cytosolic calcium concentration and ultimately results in B cell
proliferation and differentiation into cells capable of secretion of
protective antibodies (Rajewsky, 1996).Expression of the BCR is absolutely required during B cell
development both for positive selection of immature B cells
and for survival of mature B cells (Lam et al., 1997; Rajewsky,
1996), suggesting that the BCR transmits a constitutive (tonic)
signal. Although the molecular mechanism of tonic signaling
remains to be elucidated, it will probably hinge on an under-
standing of the distribution and behavior of the BCR in the resting
B cell membrane. It has been suggested that the BCR exists as
oligomers within the resting B cell membrane on the basis of
biochemical characterizations (Reth et al., 2000; Schamel and
Reth, 2000). Alternatively, fluorescence resonance energy trans-
fer failed to detect any interaction between appropriately labeled
Iga and Igb, indicating that the BCR may exist as a monomer
(Tolar et al., 2005). However, the earliest event visualized thus
far and associated with successful B cell activation is the forma-
tion of signaling BCR microclusters (Depoil et al., 2008; Weber
et al., 2008), which is dependent on the Cm4 domain of the
BCR (Tolar et al., 2009). Thus, it is clear that BCR distribution
is important for mediating BCR function. In spite of this, very little
is known concerning the nature and regulation of BCR diffusion
within the plasma membrane.
The diffusion dynamics of both transmembrane and glycosyl-
phosphatidylinositol (GPI)-anchored proteins in the plasma
membrane has been investigated via single-particle tracking
(SPT) (Kusumi et al., 1993; Saxton, 1993). These studies have
led to the postulation that membrane-protein diffusion can be
confined within membrane compartments defined by transmem-
brane protein ‘‘pickets’’ or the membrane-skeleton ‘‘fence’’
(Kusumi et al., 1993, 2005). Within the context of this model, it
is likely that the dynamic linkage of the plasma membrane to
the underlying actin cytoskeleton influences receptor diffusion
and may permit the rapid transitional ‘‘hop’’ diffusion between
compartments suggested by the membrane skeleton fence
model (Kusumi et al., 2005). One family of proteins that provides
a regulated linkage between plasma membrane proteins and the
actin cytoskeleton is the widely distributed ezrin-radixin-moesin
(ERM) protein family. Phosphorylation of ERM proteins on a thre-
onine within the C-terminal domain induces a conformational
opening of the protein to expose a FERM domain in the
N terminus and an actin-binding domain in the C terminus
(Bretscher et al., 2002). Interestingly in lymphocytes, immunore-
ceptor signaling induces the rapid and transient dephosphoryla-
tion of ERM proteins and their detachment from the actin cyto-
skeleton (Delon et al., 2001; Faure et al., 2004; Gupta et al.,Immunity 32, 187–199, February 26, 2010 ª2010 Elsevier Inc. 187
Figure 1. Steady-State BCR Diffusion within the Plasma Membrane
Is Restricted
(A–C) Single-molecule tracking of IgM and IgD in primary naive B cells on MHC
II-coated coverslips.
(A, top and middle) Different BCR behaviors identified: faster, more mobile
diffusion (top, red track) and slower, more confined diffusion (middle, blue
track).
(A, bottom) IgM (red) and IgD (green) are occasionally visualized confined in the
same volume (yellow circle). Track for IgM is shown (red).
Scale bars represent 2 mm.
(B) Diffusion coefficients of single molecules of IgM (black squares) and IgD
(gray circles) with the median indicated in red.
(C) Relative frequencies of single molecules of IgM (black squares) and IgD
(gray circles) with diffusion coefficients in the indicated diffusion bins.
(D–I) Steady-state diffusion coefficients (D, F, H) and distribution histogram
with diffusion coefficients in the indicated bins (E, G, I) of single molecules of
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However, high-resolution imaging of immunoreceptors together
with ERM proteins has not been performed.
Early biochemical and electron microscopy studies suggested
a link between BCR activation and the actin cytoskeleton
(Baeker et al., 1987; Braun et al., 1982; Hartwig et al., 1995;
Williams et al., 1994). However, a direct association between the
BCR and the actin cytoskeleton in resting cells was not detected.
Thus, we have characterized the role and functional significance
of the actin cytoskeleton in the regulation of steady-state BCR
diffusion. Here, we used high-speed dual-view acquisition total
internal reflection fluorescence microscopy (TIRFM) to simulta-
neously visualize single particles of BCR together with actin
and ezrin, a highly conserved member of the ERM family. We
show that in resting B cells, actin and ezrin together formed
a network that both defined micron-sized compartments con-
taining mobile BCRs and established boundaries to impede
BCR diffusion. The efficiency of these actin-defined boundaries
to restrict BCR diffusion was largely dependent on the cyto-
plasmic domain of Igb. Furthermore, we observed that alteration
of the actin network was sufficient to induce robust calcium
signaling comparable to that triggered by BCR crosslinking, as
well as phosphorylation of downstream signaling molecules
and upregulation of activation markers. Moreover, through the
use of an extensive panel of B cells deficient in key signaling
molecules, we show that this signaling most probably originates
from the BCR. Thus, our results suggest that the membrane skel-
eton plays an important function in controlling BCR dynamics
and signaling, thereby implicating the actin cytoskeleton in the
control of tonic BCR signaling.RESULTS
Steady-State BCR Diffusion Is Restricted within
the Plasma Membrane
To investigate the regulation of steady-state BCR dynamics,
single particles of BCR were visualized via TIRFM in naive
B cells under nonstimulatory conditions. Naive B cells express
two BCR isotypes, IgM and IgD, so we simultaneously visualized
them by labeling with a low concentration of fluorescently
labeled anti-IgM- (red) and anti-IgD- (green) specific Fab frag-
ments. As a result, approximately 1 of every 500 BCRs (see
Experimental Procedures) on the membrane were labeled. SPT
analysis of IgM and IgD revealed that the BCR did not exhibit
a single behavior, but rather some single particles of BCR were
highly mobile, whereas in other cases, diffusion was largely
restricted (Figure 1A; Movie S1 available online). Similar single-
molecule behavior for plasma membrane proteins has been
described previously (Douglass and Vale, 2005). The size, inten-
sity, and photobleaching of the Fab fragments are characteristic
for single molecules (Figure S1), indicating that we are visualizingIgM in primary naive B cells adhered to anti-MHC class II-coated coverslips
and various B cell lines adhered to fibronectin-coated coverslips (D, E), single
molecules of IgM and IgD in the IgM+IgD+ Wehi 231 B cell line (F, G), and single
molecules of transfected Hel-specific IgM or endogenous IgG in A20 B cells
(H, I). ***p < 0.0001, *p = 0.02.
300 representative diffusion coefficients displayed from a total of 500–3000
from at least two independent experiments. See also Figure S1.
Figure 2. The Cytoplasmic Domain of Igb Influences
Steady-State BCR Diffusion
(A and B) Comparison of the diffusion coefficients (A) and
distribution histogram (B) of single molecules of IgM and
MHC class II in the A20 B cell line.
(C and D) Single-molecule tracking of chimeric IgM BCRs
expressed in A20 B cells.
(C) Diffusion coefficients of single molecules of IgM-WT (blue),
IgM-H2 (red), and IgM-Mutb (green) with median indicated in
red.
(D) Relative frequencies of IgM-WT (blue), IgM-H2 (red), and
IgM-Mutb (green) with diffusion coefficients in the indicated
bins.
(E and F) Single-molecule tracking of chimeric Hel protein
expressed in A20 B cells.
(E) Diffusion coefficients of single molecules of Hel-H2 (red)
and Hel-Igb (green) with median indicated in red.
(F) Relative frequencies of Hel-H2 (red) and Hel-Igb (green)
with diffusion coefficients in the indicated bins.
***p < 0.0001. 300 representative diffusion coefficients dis-
played from a total of 500–3000 from at least three indepen-
dent experiments. See also Figure S2.
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lated from the trajectory of individual particles of IgM and IgD.
This analysis revealed a wide range of values (Figure 1B), consis-
tent with our observation of different behaviors for individual
molecules. Histograms of diffusion coefficients of both IgM
and IgD revealed a peak of very slow diffusion coefficients and
a trailing shoulder of higher values (Figure 1C). The median diffu-
sion coefficient of IgM was 10-fold greater than that of IgD (0.032
mm2s1 compared with 0.003 mm2s1) (Figure 1B). This reflected
a nearly 2-fold increase in the slow-diffusing population (left peak
of histogram) in IgD compared with IgM (Figure 1C; Movie S1). To
determine whether this distribution in diffusion was representa-
tive of a general phenomenon in the steady-state lateral diffusion
of BCRs in the plasma membrane, we measured IgM diffusion in
several cell lines (Figures 1D and 1E). The median diffusion coef-
ficient and the distribution of IgM were consistent between naive
and transformed murine B cells as well as chicken B cells.
Although to a lesser extent than in primary naive B cells, IgD
was slower than IgM in Wehi B cells (Figures 1F and 1G), sug-
gesting some isotype-specific determinants of BCR diffusion.
Similarly, IgG diffusion in murine A20 cells was slightly reduced
compared to IgM (Figures 1H and 1I). However, the distribution
of each of these isotypes exhibited a peak of very slow diffusing
BCR and a shoulder of higher values (Figures 1C, 1E, 1G, and 1I).Immunity 32,Thus, it is clear that independent of isotype,
a proportion of BCRs exhibit restricted steady-
state diffusion within the plasma membrane.
The Intracellular Domain of Igb Influences
BCR Diffusion Dynamics
In contrast to the BCR but consistent with previous
reports (Umemura et al., 2008; Vrljic et al., 2002;
Wade et al., 1989), major histocompatibility
complex class II protein (MHC II) was largely mobile
(0.15 mm2s1 compared with 0.032 mm2s1;
Figure 2A; Movie S2). Indeed, the proportion of
slow-diffusing MHC II was less than half thatobserved for IgM (Figure 2B). This suggests that a BCR-intrinsic
factor contributes to the slow-diffusing population of BCRs.
Because the diffusion of IgD may be further influenced by the
presence of a GPI-linked form of this isotype (Wienands and
Reth, 1992), and we are unable to determine the relative number
or distinguish between transmembrane and GPI-anchored
forms, we have used IgM as a model BCR for further investiga-
tion. In order to assess a potential role of the transmembrane
and intracellular domains, we tracked single molecules of
a chimeric BCR composed of the extracellular domain of IgM
fused to the transmembrane and cytoplasmic domain of MHC
class I (Williams et al., 1994) (IgM-H2) (Figure S2A). Because
naive B cells expressing this chimeric receptor do not undergo
allelic exclusion, making IgM-H2 indistinguishable from the
endogenous BCR, we expressed it in A20 B cells, which lack
endogenous IgM. The median diffusion coefficient of this
chimeric receptor was nearly three times faster than that
observed for wild-type IgM (0.088 mm2s1 compared with
0.031 mm2s1; Figure 2C). This difference was not only a result
of the nearly 50% reduction in the proportion of slow-diffusing
receptors, but also an increase in the higher values of diffusion
coefficient (Figure 2D). Similar values were obtained for MHC
class I, consistent with previous reports (Figures S2B and S2C;
Edidin et al., 1994; Tang and Edidin, 2003; Vrljic et al., 2005).187–199, February 26, 2010 ª2010 Elsevier Inc. 189
Figure 3. The Actin Cytoskeleton Defines BCR Diffusion Dynamics
in Resting B Cells
Dual-view TIRFM to simultaneously visualize Lifeact-GFP (green) and track
single molecules of IgM (A–F) or IgM-H2 (G–J) in A20 B cells on fibronectin-
coated coverslips.
(A and G) Selected TIRFM images from 200 frame/10 s time sequence at the
indicated times during tracking of IgM or IgM-H2 (red). The images in the right
panels are magnified time sequences of the left panel (white square) with an
example of a 2D trajectory of IgM (A) or IgM-H2 (G) indicated in yellow, with
the diffusing particle outlined with a white circle.
(B and H) Magnified image showing trajectories of IgM (B) or IgM-H2 (H) inside
(red) and outside (yellow) actin-rich regions (grayscale).
(C and D) Trajectories of IgM inside (C) and outside (D) actin-rich regions,
demarcated by white lines.
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the intracellular domain of Igb (Williams et al., 1994) (IgM-Mutb)
largely restored the diffusion dynamics observed for wild-type
IgM (Figures 2C and 2D; Figure S2A). Similar results were ob-
tained for primary naive B cells expressing this chimeric receptor
(data not shown). We further verified the importance of the Igb tail
in mediating restricted diffusion by generating chimeric mole-
cules composed of an unrelated protein, the small molecule
hen egg lysozyme (Hel), fused to the transmembrane and intra-
cellular domain of MHC class I (Hel-H2), or a similar molecule
in which the intracellular domain was replaced with that of Igb
(Hel-Igb; Figure S2D). The median diffusion coefficient of Hel-
H2 was very similar to that observed for IgM-H2 (0.088 mm2s1
compared with 0.084 mm2s1; Figures 2E and 2F). Consistent
with our previous results, fusion of the intracellular domain of
Igb led to reduced diffusion of the Hel protein (0.043 mm2s1;
Figures 2E and 2F). These results indicate that the intracellular
domain of the associated Igb tail, rather than the transmembrane
domain, plays an important role in mediating the restriction in
BCR diffusion.
The Actin Cytoskeleton Defines Barriers that Limit
BCR Diffusion
The actin cytoskeleton has been implicated in restricting the
diffusion of many cell surface proteins (Charrier et al., 2006;
Fukatsu et al., 2004; Haggie et al., 2006; Lenne et al., 2006;
Sheetz et al., 1980; Suzuki et al., 2005; Wheeler et al., 2007).
Furthermore, it has recently been reported that the actin cyto-
skeleton confines mobile Fc3RI in a rat basophilic cell line
(Andrews et al., 2008). Because the cytoplasmic domain of Igb
was important for restricting BCR diffusion, we were keen to
examine whether this was due to an actin-mediated regulation
of BCR diffusion dynamics. We simultaneously visualized the
BCR and the actin cytoskeleton in B cells expressing a marker
of filamentous actin (F-actin), Lifeact-GFP (Riedl et al., 2008).
By using TIRFM we were able to focus our analysis only on the
portion of the actin cytoskeleton that is in close proximity to
the plasma membrane (150 nm) and observed an intricate
network containing regions of high and low actin density
(Figure 3A). We observed that single molecules of BCR exhibiting
limited mobility were trapped within regions rich in actin fila-
ments (Figure 3A; Movie S3). In contrast, BCR diffusion was
increased within actin-poor areas; however, the boundaries for
diffusion tracks within these regions are still defined by the actin
network, which appears to act as a diffusion barrier (Figure 3A;
Movie S3). Indeed, we observed that mobile single particles of
BCR become confined once entering an actin-rich region
(Figure 3A; Movie S3). Notably, there was relatively little F-actin
reorganization on the time scale of acquisition (10 s), except in
peripheral filopodia where linear diffusion of the BCR was(E and I) Diffusion coefficients of single molecules of IgM or IgM-H2 inside
(circles) and outside (triangles) actin-rich areas with the median indicated by
red bar.
(F and J) Relative frequencies of single molecules of IgM (F) or IgM-H2 (J) inside
(circles) and outside (triangles) actin-rich areas with diffusion coefficients in the
indicated bins.
Scale bar represents 2 mm. ***p < 0.0001. 300 representative diffusion coeffi-
cients from a total of 500–3000 from at least three independent experiments.
See also Figure S4.
Figure 4. The Membrane Cytoskeleton Linker Protein Ezrin Regu-
lates BCR Diffusion in Resting B Cells
(A) Dual-color TIRFM to visualize the distribution of Lifeact-mRFPruby (red)
together with Ezrin-GFP (cyan) in A20 B cells on fibronectin-coated coverslips.
(B) Selected pseudocolor TIRFM images of magnified view of Ezrin-GFP from
(A) indicated by white square. Threshold outline (white) shows rapidly modified
ezrin ‘‘holes.’’
(C–H) Dual-view TIRFM to simultaneously visualize ezrin-GFP (cyan) and track
single molecules of IgM (BCR) in A20 B cells on fibronectin-coated coverslips.
(C) Selected TIRFM images from 200 frames/10 s time sequence at the indi-
cated times during tracking of BCR (red). The images in the right panels are
magnified time sequence images of the left panel (white square) with an
example of a 2D trajectory indicated in yellow, with the diffusing particle out-
lined with a white circle.
(D) Magnified image showing 2D trajectories of BCR inside (red) and outside
(yellow) ezrin-rich regions (grayscale). Magnified trajectories of IgM (E) inside
(red) and (F) outside (yellow) ezrin-rich regions demarcated by white lines.
(G) Diffusion coefficients of single molecules of BCR inside (circles) and
outside (triangles) ezrin-rich areas with the median indicated by red bar.
(H) Relative frequencies of single molecules of BCR inside (circles) and
outside (triangles) actin-rich areas with diffusion coefficients in the indicated
bins.
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tures are distinct from the cell cortex, we excluded these struc-
tures from our analysis of the regulation of BCR diffusion
dynamics.
To examine the diffusion of the BCR in relation to actin, we
defined masks (Supplemental Experimental Procedures,
Figure S4) based on the fluorescence intensity of Lifeact-GFP
and plotted single-molecule tracks of at least 10 frames (500
ms) ‘‘inside’’ or ‘‘outside’’ actin-rich regions (Figures 3B–3D).
We observed that the rate of diffusion is inversely related to
the density of actin filaments, such that BCRs in actin-rich areas
have reduced mobility while diffusion is increased in actin-poor
regions. The median diffusion coefficient of IgM was decreased
more than 50% inside actin-rich regions compared to outside
actin-rich regions (0.014 mm2s1 compared with 0.039 mm2s1)
(Figure 3E). This decrease reflected a substantial increase in
the proportion of slow-diffusing BCR inside actin-rich regions
(Figure 3F). Similar BCR behavior in relation to actin was
observed in B cells settled on planar lipid bilayers containing
ICAM-1 (data not shown). Importantly, the wild-type BCR rarely
crossed actin-rich areas (Movie S3). In contrast, highly mobile
molecules of the chimeric IgM-H2 BCR frequently traversed
actin-rich regions (Figure 3G; Movie S4). Indeed, analysis of
these tracks in relation to actin-rich regions revealed a marked
decrease in the frequency of slow-diffusing IgM-H2 and
a concomitant increase in the proportion of more mobile BCR
(Figures 3H–3J). The median diffusion coefficient both inside
and outside actin-rich regions was increased by more than
2-fold compared to wild-type IgM (inside, 0.048 mm2s1
compared with 0.014 mm2s1; outside, 0.108 mm2s1 compared
with 0.039 mm2s1) (Figure 3I). Although IgM-H2 molecules with
slower diffusion in actin-rich regions were observed, the propor-
tion of these molecules was reduced by nearly 50% compared to
wild-type IgM (compare Figures 3F and 3J). These results
suggest that the actin cytoskeleton influences steady-state
BCR dynamics by defining barriers that limit diffusion. Moreover,
it is clear that the intracellular domain of Igb makes a substantial
contribution to the efficiency of actin-mediated restriction of
BCR diffusion.
The Ezrin-Mediated Link between the Plasma
Membrane and the Actin Cytoskeleton
Regulates BCR Diffusion
Interestingly, although the majority of slow-diffusing BCR were
observed in actin-rich regions, we also observed slow-diffusing
BCR outside actin-rich regions. We reasoned that the linkage
between components of the plasma membrane and underlying
actin filaments might influence BCR dynamics. The ezrin-radi-
xin-moesin (ERM) family proteins seem likely candidates to
mediate such a linkage (Bretscher et al., 2002), so we expressed
and visualized ezrin-GFP in B cells. Similar to that observed for
actin, under steady-state conditions, ezrin-GFP forms an intri-
cate network (Figure 4A). Interestingly, when simultaneously
visualized, we found that although similar, the density of these
two networks is not fully coincident (Figure 4A; Movie S5). This***p < 0.0001. Scale bars represent 2 mm. 300 representative diffusion coeffi-
cients displayed from a total of 500–3000 from at least three independent
experiments. See also Figure S5.
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Figure 5. Alteration of the Actin Cytoskel-
eton Is Sufficient to Induce BCR Signaling
(A–H) Alteration of the actin cytoskeleton induces
intracellular signaling.
(A–E) Ratiometric intracellular Ca2+ flux in primary
naive B cells upon addition (indicated by black
arrow) of vehicle control (DMSO) (A), 5 mg/ml
anti-IgM F(‘ab)2 (B), 0.5 mM LatA (C), 10 mM CytoD
(D), or 1 mM JP (E) measured by flow cytometry.
Mean indicated by red line.
(F) Primary naive B cells were treated with 0.5 mM
LatA (+) or vehicle control (DMSO) (–) at 37C for
the indicated time. Cells were lysed and analyzed
by SDS-PAGE followed by immunoblotting with
anti-phospho-p44 and 42 MAPK (Erk1 and 2),
anti-phospho-Akt, or anti-p44 and 42 MAPK.
(G) Quantification of the fold increase in pERK and
pAkt upon LatA treatment.
(H) Primary naive B cells were treated or not (gray
shaded) with 0.5 mM LatA (red line), 10 mM Cyto D
(blue line), 1 mM JP (green line), or 5 mg/ml anti-IgM
F(‘ab)2 (black dotted line) for 5 min and then
cultured for 24 hr. Cells were stained for the activa-
tion marker CD86 and analyzed by flow cytometry.
(I–L) Signaling induced by alteration of actin is
predominantly mediated via the BCR. Ratiometric
intracellular Ca2+ flux in primary wild-type (WT),
PLCg2-deficient, and Vav1 and 2 double-deficient
B cells treated with 0.5 mM Lat A (I) or 200 ng/ml
SDF-1 (J) measured by flow cytometry.
(K) Wild-type DT40 and various signaling-deficient
cells including Lyn/ (Lyn-KO), Blnk/ (BLNK-
KO), Btk/ (Btk-KO), Plcg2/ (PLCg2-KO),
Itpr1/Itpr2/Itpr3/ (IP3R-KO), Vav3/
(Vav3-KO), and Pik3ca/ (PI3K-KO) were treated
with 0.5 mM LatA or vehicle control (DMSO) for
5 min at 37C. Cells were lysed and analyzed by
SDS-PAGE followed by immunoblotting with
anti-phospho-p44 and 42 MAPK (Erk1 and 2)
and anti-p44 and 42 MAPK.
(L) Quantification of the induction of pERK upon
LatA treatment shown in (K).
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not easily visualized under TIRF illumination. Furthermore, at the
frame rate used for single-particle tracking, small dynamic
‘‘holes’’ in the ezrin network could be detected, suggesting
that this protein rapidly regulates interactions between the actin
cytoskeleton and the plasma membrane and thus may influence
BCR diffusion (Figure 4B; Movie S5).
To investigate this role for ezrin, we visualized the distribution
of ezrin-GFP together with the BCR. The BCR was largely slow
moving, or confined, within ezrin-rich regions and more mobile
in regions of reduced ezrin intensity (Figures 4C–4F; Movie S6).
In contrast to actin, ezrin-GFP was more rapidly reorganized
and appeared to create ‘‘gates’’ allowing the BCR to transition
between compartments (Figure 4C; Figure S5, Movie S6). The
median diffusion coefficient was three times slower inside
ezrin-rich regions compared to outside ezrin-rich regions
(0.011 mm2s1 compared with 0.037 mm2s1; Figure 4G), as
a result of the markedly increased frequency of slow-diffusing
BCR inside ezrin-rich regions (70% compared to 45%;
Figure 4H). Moreover, we observed BCR confined in small
spaces between ezrin-rich regions (Figure 4F), suggesting that192 Immunity 32, 187–199, February 26, 2010 ª2010 Elsevier Inc.the surrounding ezrin network limits BCR mobility. These results
indicate that the ezrin-mediated linkage of the plasma mem-
brane to actin filaments provides a mechanism for regulating
steady-state BCR diffusion dynamics.
Alteration of the Actin Cytoskeleton Is Sufficient
to Induce Signaling
To assess the functional significance of this ezrin- and actin-
mediated restriction in BCR diffusion in steady-state B cells,
we monitored intracellular calcium flux by flow cytometry upon
treatment of cells with pharmacological agents of actin alter-
ation. Latrunculin A (LatA) treatment is sufficient to induce robust
calcium signaling comparable to that induced by crosslinking
IgM (Figures 5A–5C). Similar results were obtained upon treat-
ment of cells with the fungal toxin Cytochalasin D (CytoD), which
binds to the barbed ends of actin filaments and thus disrupts
actin polymerization (Figure 5D). Jasplakinolide (JP), an actin-
stabilizing drug, in vitro also induced robust calcium signaling
(Figure 5E). To determine whether alteration of the actin cyto-
skeleton was sufficient to induce other signaling pathways, we
examined phosphorylation of downstream signaling molecules
Immunity
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phorylation of these substrates upon disruption of the actin cyto-
skeleton (Figures 5F and 5G). Moreover, we detect upregulation
of the activation marker CD86 1 day after a brief treatment of
primary naive B cells with actin-disrupting agents (Figure 5H).
Taken together, these results indicate that the signaling induced
by disruption of the actin cytoskeleton is sufficient to induce not
only early signaling events but also expression of costimulatory
molecules. These observations suggest that the actin cytoskel-
eton plays an important role in regulating signaling in B cells.
Actin Alteration-Induced Signaling Is Probably
Mediated by the BCR
Given that the BCR is among the most abundant cell surface
receptor in naive B cells (250,000/B cell, data not shown), we
were keen to determine whether this signaling induced by actin
alteration is mediated predominantly through the BCR. Indeed,
calcium signaling upon disruption of the actin cytoskeleton
with LatA is abrogated in primary naive B cells that lack key
downstream regulators of BCR signaling, such as PLCg2 and
Vav (Figure 5I). Similar results were obtained upon treatment
with CytoD and JP (data not shown). In contrast, no substantial
difference in calcium signaling in response to the chemokine
SDF-1 was observed in PLCg2 or Vav1 and 2 deficient B cells
compared to wild-type B cells (Figure 5J), demonstrating that
the lack of calcium flux in these cells upon treatment with
actin-disrupting agents is not simply due to an intrinsic defect
in the calcium pathway. In order to genetically dissect this
signaling pathway, we examined a panel of DT40 B cells defi-
cient in a number of key signaling molecules. We observed
that, consistent with primary naive murine B cells, treatment of
DT40 B cells with LatA induced rapid phosphorylation of ERK
(Figures 5K and 5L). In contrast, phosphorylation of ERK was
abrogated in DT40 B cells lacking key BCR signaling molecules,
including Lyn, BLNK, Btk, and PLCg2 (Figures 5K and 5L).
However, alteration of F-actin induced phosphorylation of ERK
in IP3R-, Vav3-, and PI3K-deficient cells (Figures 5K and 5L),
consistent with ERK activation upon BCR-crosslinking as previ-
ously reported (Fujikawa et al., 2003; Hashimoto et al., 1998; Ok-
kenhaug et al., 2002). These results provide genetic evidence
that alteration of the actin cytoskeleton induces signaling in
steady-state B cells, which is probably mediated by the BCR.
Actin Alteration Increases BCR Diffusion
To gain insight into this actin-induced signaling, we assessed
how alteration of the actin- and ezrin-defined membrane skel-
eton affected BCR diffusion. Treatment of Lifeact-GFP-express-
ing B cells with the actin-depolymerizing drugs LatA or CytoD
was sufficient to observe a considerable disruption of the actin
network, without drastic alteration of B cell morphology
(Figure 6A; Movie S7). Somewhat surprisingly, treatment with
JP also rapidly disrupted the actin cytoskeleton, as seen by
the diminished intensity of Lifeact-GFP (Figure 6A; Movie S7).
Biochemical analysis confirms the polymerization of F-actin after
treatment with JP, consistent with the reported effect of JP.
However, substantial alterations in the actin cytoskeleton upon
treatment with JP were clearly observed by the increased inten-
sity of Actin-GFP within patches at the membrane and intracel-
lular regions via confocal microscopy (Figure S6). We treatednaive primary murine B cells with these pharmacological agents
to determine the effect of cytoskeleton alteration on BCR diffu-
sion. LatA treatment immediately gives rise to a nearly 3-fold
increase in the median diffusion coefficient of the BCR (0.032
mm2s1 to 0.086 mm2s1; Figures 6B and 6C), reflecting both
a decrease in the slow-diffusing population and an increase in
the faster-diffusing populations (Figure 6C). Similarly, treatment
of B cells with CytoD caused a 3-fold increase in the median
diffusion coefficient of the BCR (0.032 mm2s1 to 0.095 mm2s1;
Figures 6B and 6C). BCR diffusion was also markedly increased
upon treatment of B cells with JP (Figure 6B), which reflected
a substantial reduction in the slow-diffusing population (Fig-
ure 6C). Interestingly, we also observed a nearly 10-fold increase
in the median diffusion coefficient of IgD after treatment with
LatA, indicating that the actin cytoskeleton is an important regu-
lator of BCR diffusion independent of isotype (Figures 6D and
6E). In line with this, overexpression of a dominant-negative
form of ezrin, which lacks the actin-binding domain (Ezrin-310)
and therefore disrupts the linkage between the plasma
membrane and actin filaments, increased the median BCR diffu-
sion coefficient (Figure 6F). In contrast, overexpression of a
constitutively active form of ezrin (Ezrin-TD) markedly decreased
BCR diffusion (Figure 6G). Taken together, these results demon-
strate that alteration of the membrane skeleton in steady-state
B cells causes an increase in BCR diffusion, which may be linked
to the induction of signaling.
BCR Diffusion Correlates with Signaling
In order to determine whether the observed signaling was related
to the rate of BCR diffusion, we titrated the concentration of
CytoD used to induce calcium signaling from 0.5 mM to 10 mM.
We detected negligible calcium flux at the lowest concentration
of CytoD and incremental increases in calcium flux from 2 mM to
10 mM (Figure 6H). We determined that a similar population of
cells was fluxing calcium, but that the peak flux increased with
increasing CytoD (data not shown). We also measured a
concomitant increase in the median diffusion coefficient of the
BCR with increasing concentrations of CytoD (Figure 6I). This
increase reflected a step-wise decrease in the proportion of
very-slow-diffusing BCR (far left peak of histogram) with
increasing concentration of CytoD (Figure 6J). Thus, we found
that increasing concentrations of CytoD resulted in a similar
concomitant increase in calcium as well as in the proportion of
mobile BCR. Moreover, we find a strong correlation between
the integrated area under the calcium curve and the mobile frac-
tion of the BCR (Figure 6K). These results suggest that the
signaling induced upon alteration of the actin cytoskeleton may
be related to changes in BCR diffusion dynamics.
BCR signaling after antigen engagement induces dramatic
cytoskeleton reorganization (Arana et al., 2008; Fleire et al.,
2006; Lin et al., 2008). Thus, it seems plausible that BCR expres-
sion alone might produce a low-intensity signal (Lam et al., 1997;
Rajewsky, 1996) that may to some degree regulate steady-state
actin organization or dynamics. In line with this, we observed that
B cells deficient in Syk, one of the earliest tyrosine kinases acti-
vated upon BCR stimulation, had dramatically altered organiza-
tion of the actin cytoskeleton (Figures 7A and 7B). Indeed, we
observed an increased number of actin-rich filopodia in which
linear diffusion of the BCR prevented us from further analysisImmunity 32, 187–199, February 26, 2010 ª2010 Elsevier Inc. 193
Figure 6. Signaling Induced by Disruption of Actin Correlates with
BCR Diffusion
(A–E) Pharmacological agents of actin disruption increase BCR diffusion.
(A) Lifeact-GFP-expressing cells were visualized by TIRFM before (top) and
5 min after treatment (bottom) with 0.5 mM LatA, 10 mM CytoD, or 2 mM JP.
(B and C) Single-molecule tracking of IgM in primary naive B cells on MHC II-
coated coverslips upon treatment with 0.5 mM LatA (red), 10 mM CytoD (blue),
2 mM JP (green), or vehicle control (DMSO; black). Diffusion coefficients with
the median indicated in red (B) and distribution histogram (C) with diffusion
coefficients in the indicated bins.
(D and E) Single-molecule tracking of IgD in primary naive B cells treated with
0.5 mM LatA (red squares) or vehicle control (black circles). Diffusion coeffi-
cients with the median indicated in red (D) and distribution histogram (E)
with diffusion coefficients in the indicated bins.
(F and G) Genetic alteration of membrane-cytoskeleton link modifies BCR
diffusion. Diffusion coefficients of single molecules of BCR in A20 B cells
expressing wild-type ezrin-GFP (circles) and ezrin-310-GFP (squares) (F) or
DT40 B cells expressing wild-type ezrin-GFP (circles) and ezrin-TD-GFP
(squares) (G) with the median indicated in red.
(H–K) Increasing concentrations of CytoD increase intracellular calcium flux
and the mobile fraction of the BCR.
(H) Ratiometric intracellular Ca2+ flux in primary naive B cells treated with
0.5–10 mM CytoD measured by flow cytometry.
(I and J) Diffusion coefficients (I) and distribution histogram (J) of single mole-
cules of IgM in primary naive B cells upon treatment with increasing concen-
trations of CytoD.
(K) The integrated area under the calcium curve in (H) was plotted against the
mobile fraction (all bins except lowest) of the BCR from (J).
***p < 0.0001. 300 representative diffusion coefficients displayed from a total of
500–3000 from at least two independent experiments. See also Figure S6.
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194 Immunity 32, 187–199, February 26, 2010 ª2010 Elsevier Inc.of BCR diffusion in these cells (Figure S3). Similar results were
observed in B cells deficient in the Src-family kinase Lyn (data
not shown). Consistent with these observations, we found that
treatment of primary naive B cells with the Syk inhibitor, Piceata-
nol, dramatically altered cell morphology (M.W. and F.D.B.,
unpublished). Nonetheless, we were able to measure BCR diffu-
sion in primary naive B cells deficient in PLCg2 and Vav1 and 2,
where the actin network does not appear to be as substantially
altered. We observed that IgM diffusion is decreased in both
PLCg2- and Vav1- and 2-deficient B cells (Figure 7C). This
decrease reflected a 20% increase in the slow-diffusing popula-
tion (Figure 7D). Taken together, these results suggest that
perhaps tonic signaling through the BCR may also influence
steady-state actin dynamics or organization (Figure S7). Such
interplay between tonic BCR signaling and actin dynamics may
provide a mechanism for regulating this low-level constitutive
signaling.DISCUSSION
By using dual-view TIRF acquisition, we were able to simulta-
neously measure the steady-state diffusion of the two BCR iso-
types expressed by naive B cells. We observed that diffusion of
both IgM and IgD is restricted within the plasma membrane.
Interestingly, the proportion of BCR that was very slow diffusing
was greater for IgD compared to IgM. The reason for the
increased immobility of IgD has yet to be identified but may be
due to the presence of both transmembrane and GPI-anchored
forms, which could alter microdomain association (Chaturvedi
et al., 2002; Wienands and Reth, 1992). Moreover, we previously
observed that IgD appears to be preclustered (Depoil et al.,
Figure 7. BCR Diffusion Is Decreased in B Cells Deficient in PLCg2
and Vav1/2
(A and B) Signaling-deficient B cells have altered actin cytoskeleton.
(A) DT40 WT or Syk-deficient B cells were allowed to settle on fibronectin-
coated coverslips and cell morphology and adhesion were examined by differ-
ential interference contrast (DIC) and interference reflection microscopy (IRM).
(B) DT40 WT and Syk-deficient B cells on fibronectin-coated coverslips were
fixed and F-actin was stained with phalloidin and visualized by TIRFM.
Scale bars represent 2 mm.
(C and D) Signaling-deficient B cells have reduced IgM diffusion. Single-mole-
cule tracking of IgM in primary naive B6 (black circle), PLCg2-deficient (green
square), and Vav1 and 2 double-deficient (blue triangle). Diffusion coefficients
(C) and distribution histogram (D) with diffusion coefficients in the indicated
bins. Median indicated by red line. ***p < 0.0001. 300 representative diffusion
coefficients displayed from a total of 500–3000 from at least two independent
experiments. See also Figure S7.
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Indeed, it should be noted that although we are able to visualize
single particles of BCR, we do not know whether these particles
are monomers or oligomers (Schamel and Reth, 2000) or even
higher-order ‘‘protein islands’’ (Lillemeier et al., 2006).
We have identified the intracellular domain of Igb as a crucial
element for the restriction in BCR diffusion. Simply substituting
the intracellular domain of Igb with that of MHC class I increased
BCR diffusion nearly 3-fold. The intracellular domain of Igb and
MHC class I do not differ greatly in size, particularly in compar-
ison to the whole protein, so it is unlikely that the difference in
diffusion is merely size-dependent slowing. Instead, our data
suggest that Igb increases the efficiency of actin-mediated
restriction in BCR diffusion. It remains to be determined whether
this is due to a specific interaction between Igb and actin, or
whether a difference in the length or tertiary structure of the cyto-
plasmic domain of Igb and MHC class I affects their trapping by
the membrane skeleton (Edidin et al., 1994). Also, it is possible
that some of this difference in diffusion may be due to a difference
in the net charge of the cytoplasmic domain, which could affectits affinity for proteins in the cytoplasm or electrostatic interac-
tions with phospholipids in the plasma membrane (Xu et al.,
2008). The very small difference between the IgM-Mutb chimeric
receptor and the diffusion dynamics of the wild-type receptor
suggests that the transmembrane domain may also influence
BCR diffusion, possibly through interaction with other proteins,
such as CD19 and/or CD21 (Carter et al., 1997); the formation
of BCR oligomers (Schamel and Reth, 2000); or microdomain
association, which could influence additional factors such as
molecular crowding (Dix and Verkman, 2008; Zhou, 2009).
A recent study examining the role of the extracellular Cm4
domains in BCR clustering upon antigen stimulation noted that
a proportion of BCR are immobile in unstimulated cells (Tolar
et al., 2009). However, the mechanism or functional relevance
of this observation was not investigated. Here, simultaneous
visualization of two parameters has allowed us to investigate
the mechanism that restricts steady-state BCR diffusion. We
find that BCR diffusion is highly reduced within actin-rich
regions, which may consist of membrane compartments on
the nanometer scale as suggested by the membrane skeleton
fence model (Kusumi et al., 2005). Moreover, we observe that
this network defines micron-sized compartments, consistent
with recent SPT observations of Fc3RI in a basophilic cell line
(Andrews et al., 2008). However, this work did not report highly
restricted diffusion of Fc3RI within actin-rich regions, so it
remains to be determined whether our observations reflect
a general phenomenon for ITAM-containing immunoreceptors.
Here we directly visualize how the dynamic linkage of the
plasma membrane to the actin cytoskeleton influences diffusion.
We identify the ERM protein ezrin as an important component
regulating this interaction and defining BCR diffusion. We find
that ezrin defines compartments or ‘‘corrals’’ that restrict diffu-
sion as proposed in early models (Saxton, 1995; Sheetz, 1983;
Sheetz et al., 1980). No doubt additional structural proteins of
the membrane skeleton, such as gelsolin, villin, or spectrin, are
likely to also participate in the regulation of diffusion. What’s
more, we observed rapid remodeling of the ezrin network and
propose that ezrin provides a mechanism to very quickly modify
membrane protein diffusion. Indeed, our visualization of ezrin
while simultaneously tracking the BCR suggests that such
proteins dynamically ‘‘gate’’ (Tsuji and Ohnishi, 1986) the diffu-
sion of membrane proteins and may permit the transitional
‘‘hop’’ between compartments observed in previous SPT studies
(Fujiwara et al., 2002; Kusumi et al., 1993). Moreover, receptor
signaling could regulate such a linkage (Delon et al., 2001; Faure
et al., 2004; Gupta et al., 2006) and thus fine tune diffusion
dynamics during activation. We posit that antigen-engaged
BCRs probably trigger a localized dephosphorylation of ERM
proteins and detachment of the membrane skeleton, thus
altering diffusion of unengaged BCR in close proximity, which
may then gain accessibility to ligand or BCR microclusters.
Importantly, we find that gross alteration of the actin cytoskel-
eton is sufficient to trigger B cell signaling to a similar extent as
BCR crosslinking. Moreover, we demonstrate that this signaling
is most probably mediated via the BCR and is correlated with
increased BCR diffusion. It is therefore conceivable that the
steady-state dynamism of the actin cytoskeleton, that is, small
constitutive alterations in the organization of F-actin, provides
a mechanism to generate low-intensity tonic BCR signaling.Immunity 32, 187–199, February 26, 2010 ª2010 Elsevier Inc. 195
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cytoskeleton. Indeed, we know that ligand-induced BCR
signaling rapidly alters the organization of F-actin (Hao and
August, 2005). Thus, we suggest that tonic BCR signaling may
influence actin organization and dynamics. In line with this, B
cells lacking key BCR signaling molecules have dramatically
altered steady-state morphology (Weber et al., 2008). Moreover,
IgM diffusion is decreased in B cells deficient in PLCg2 and Vav1
and 2. These results imply an interplay between BCR signaling
and the actin cytoskeleton, which probably contributes to the
regulation of tonic signaling in B cells.
At present, it is not clear how alteration of the actin cytoskel-
eton triggers BCR signaling. According to the oligomeric BCR
complex model (Reth et al., 2000; Schamel and Reth, 2000),
association of antigen with pre-existing BCR oligomers induces
a disruption of the oligomeric complex permitting accessibility
and phosphorylation of Iga-b and the activation of signaling.
Perhaps the actin cytoskeleton has a role in maintaining this
complex. Interestingly, recent electron microscopy studies
have shown that the TCR exists within higher-order protein
islands that are connected to the actin cytoskeleton and depend
on it for their formation and/or maintenance (Lillemeier et al.,
2006). It may be that the oligomeric BCR complex is linked to
actin and alteration of F-actin causes a similar disruption to the
oligomeric complex induced by antigen and thus triggers BCR
signaling. Dynamic actin remodeling might then be important
for subsequent internalization of active BCR from the cell surface
resulting in signal termination, as previous studies have sug-
gested (Stoddart et al., 2005). It has also been suggested that
the BCR undergoes clustering and a conformational opening of
Iga-b upon antigen binding, which is dependent on association
of the BCR with distinct lipid domains (Tolar et al., 2005). It
may be that disruption of the actin cytoskeleton alters the local-
ization of BCR and lipid rafts, possibly bringing together these
membrane domains.
However, our data suggest that signaling induced by disrup-
tion of actin may be related to a change in BCR diffusion. Two
possible models can be envisaged to account for our results.
One model is that the membrane skeleton restricts BCR mobility
and may thus restrict the interaction between the BCR and cor-
eceptors or activated signaling molecules. Disruption of the
diffusion barrier increases the mobile fraction of the BCR and
may thus increase the probability that the BCR will encounter
an activated kinase or coreceptor such as CD19. Alternatively,
it may be that the actin cytoskeleton affects the segregation of
kinases or phosphatases from the BCR during the steady state.
For example, the actin cytoskeleton may immobilize BCRs and
phosphatases together and disruption of F-actin releases this
inhibitory interaction as BCRs diffuse away. An important param-
eter to determine will be whether the number of cell surface
BCRs alters the signaling induced by disruption of the actin cyto-
skeleton, as well as the location of tyrosine kinases, protein
phosphatases, and coreceptors. Future research investigating
the locations of these activating and inhibitory molecules in rela-
tion to actin may shed light on these potential models.
Our data provide convincing evidence that an ezrin- and actin-
defined network influences steady-state BCR diffusion
dynamics by creating barriers that restrict BCR diffusion. We
identify the intracellular domain of Igb as important for the effi-196 Immunity 32, 187–199, February 26, 2010 ª2010 Elsevier Inc.ciency of this restriction in BCR diffusion. Importantly, alteration
of this network is sufficient to induce robust intracellular
signaling, in the absence of antigen stimulation, which is
concomitant with an increase in BCR mobility. Moreover, we
show that this signaling is most probably initiated by the BCR.
Thus, our results suggest that the membrane skeleton plays an
important function in controlling BCR dynamics and thereby
signaling in a way that could be important for understanding
both tonic and antigen-induced signaling.
EXPERIMENTAL PROCEDURES
Cell Preparation and Culture
C57BL/6 wild-type mice, MD4 (HEL-specific BCR) (Goodnow et al., 1988), and
Plcg2fl/fl Cd19Cre+/ mice (Hashimoto et al., 2000) were kindly provided by
T. Kurosaki, RIKEN (Japan), and Vav1/Vav2/ mice (Doody et al., 2001),
kindly provided by M. Turner, Babraham Institute (Cambridge, UK), were
used. Splenic naive B cells were purified as described previously (Carrasco
et al., 2004). This purification resulted in a population with 95%–98% B cells.
Primary B cells and A20 B cells expressing IgM, IgM-H2, IgM-Mutb (Williams
et al., 1994) or Hel-H2, and Hel-Igb were cultured in RPMI 1640 containing
10% FCS, penicillin and streptomycin antibiotics (Invitrogen, Carlsbad, CA),
and 50 mM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO). Wehi 231
(ATCC CRL-1702) B cells were cultured in DMEM supplemented with 10%
FCS and 50 mM 2-mercaptoethanol. Lyn/, Blnk/, Btk/, Plcg2/,
Itpr1/Itpr2/Itpr3/, Vav3/, Pik3ca/, and WT DT40 cells were used
(Shinohara and Kurosaki, 2006). DT40 cells were cultured at 39.5C in RPMI
1640 containing 10% FCS, 1% chicken serum, penicillin and streptomycin
antibiotics (Invitrogen), and 50 mM 2-mercaptoethanol (Sigma-Aldrich). All
experiments were approved by the Cancer Research UK Animal Ethics
Committee and the UK Home Office.
Cloning of Recombinant Lysozymes
For the generation of Hel-H2 and Hel-Igb chimeras, Hel sequence was ampli-
fied by PCR from a pcDNA3 plasmid containing a Hel-cDNA fragment (Batista
and Neuberger, 1998) with the sense primer 50 CGGAATTCATGAGGTCTTTGC
TAATC 30 and antisense primer 50 CGGGATCCAGATCCGCTTCCACC 30 and
cloned in the pCDNA3.1 expression vector in EcoRI and BamHI restriction
sites. H2 and Igb sheaths were amplified with pSV2gpt plasmids containing
IgM-H2 or IgM-Igb as templates described previously (Aluvihare et al., 1997).
Fragments were amplified with the sense primer 50 CGGGATCCCCTCCTC
CATCCACT 30 and the antisense primers 50CGCCTTAAGTCACGCTAGAGAA
TGAGG 30 (HEL-H2) or 50 GCGCTTAAGTCATTCCTGGCCTGG 30 (HEL-Igb)
and cloned in the Hel-pCDNA3.1 vector in BamHI and AflII restriction sites.
Reagents
Latrunculin A, Cytochalasin D, and Jasplakinolide was purchased from Calbio-
chem. For BCR diffusion analysis, 0.5 mM LatA, 0.5–10 mM Cytochalasin D, or
1 mM Jasplakinolide prewarmed in PBS was injected into FCS2 chambers
during imaging. Ezrin-GFP, Ezrin-310-GFP, and Ezrin-TD-GFP constructs
were kind gifts from E. Sahai (London Research Institute, CRUK) (Sahai and
Marshall, 2003). Lifeact-GFP and Lifeact-mRFPruby (Riedl et al., 2008) were
kindly provided by M. Sixt (Max Plank Institute of Biochemistry, Munich).
Glass Coverslip Coating
Acid-cleaned glass coverslips were incubated with either 1 mg/ml of anti-
MHCII (M5/114; ATCC TIB120) for 4 hr, 4 mg/ml (A20 B cells) or 0.5 mg/ml
(DT40 B cells) fibronectin (Sigma-Aldrich) for 1 hr and washed with PBS.
Cell Labeling for Single-Particle Tracking
Primary naive and A20 B cells were labeled with Cy3-labeled goat anti-mouse
IgM Fab fragment (Jackson Immunoresearch) or Cy3-labeled goat anti-mouse
IgG Fab fragment (Jackson Immunoresearch), or unconjugated Fabs were
labeled with AlexaFluor-555 (Molecular Probes) or Attotec 633 (Attotec)
according to manufacturer’s instructions. B cells were incubated with one of
the following: 1 ng/ml of labeled anti-IgM mixed with 2 mg/ml of unlabeled
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mixed with 4 mg/ml unlabeled anti-IgD Fab, 10 ng/ml of labeled anti-MHCII
Fab mixed with 1 mg/ml of unlabeled anti-MHCII Fab, 160 ng/ml of labeled
anti-MHCI mixed with 4 mg/ml unlabeled anti-MHCI, 80 ng/ml labeled anti-
Hel mixed with 4 mg/ml unlabeled anti-Hel, or 600 ng/ml of labeled anti-chicken
IgM Fab in chamber buffer for 15 min at 4C, then washed with PBS.
Preparation of Fab Fragments of Monoclonal Antibodies
Fab fragments of purified monoclonal antibodies to murine IgD (11-26c),
MHCII (M5/114; ATCC TIB120), MHCI (K918), Hel (D1.3), and chicken IgM
(M1) were prepared as previously described (Depoil et al., 2008). Anti-IgD,
anti-MHCII, and anti-chicken IgM were labeled with AlexaFluor dye according
to manufacturer’s instructions (Molecular Probes).
Calcium Flux by Flow Cytometry
Intracellular Ca2+ flux was measured by flow cytometry with a ratiometric indi-
cator. Primary naive B cells were preloaded with 3 mM Indo-1 AM (Molecular
Probes, Invitrogen) in RPMI at 37C for 20 min. After collecting a baseline
reading for 30 s, 0.5 mM LatA, 0.5–10 mM Cytochalasin D, 1 mM Jasplakinolide,
5 mg/ml anti-IgM F(ab’)2 (Jackson), or 200 ng/ml murine SDF-1a (Peprotech)
was added to the facs tube, and the ratio of fluorescence (405/525 nm) was
determined for 300 s with a LSRII cytometer (BD Biosciences).
Cell Stimulation and Immunoblotting
Primary naive, A20, and DT40 B cells were equilibrated in RPMI at 37C for
10 min and then 0.5 mM LatA prewarmed in PBS was added for the indicated
time. Cells were lysed in 23 Laemelli sample buffer and analyzed by SDS-
PAGE followed by immunoblotting with anti-phospho-p44 and 42 MAPK
(Erk1 and 2), anti-phospho-Akt, or anti-p44 and 42 MAPK (all from Cell
Signaling).
G-Actin/F-Actin In Vivo Assay
Primary naive B cells were treated or not with 1 mM jasplakinolide for the indi-
cated time, lysed, and fractionated according to the manufacturer’s protocol
(Cytoskeleton). Soluble and insoluble fractions were separated by SDS-
PAGE and immunoblotted for mouse b-actin (Sigma). F-actin content was
calculated by the total intensity of insoluble/(insoluble + soluble) fractions
and is represented as a percentage.
Fluorescence Recovery after Photobleaching
Experiments were performed on a multiphoton microscope (Olympus Fluo-
view FV1000 MPE2 Twin system) with a 253 1.05 NA water-immersion objec-
tive (Olympus XLPLNWMP) and Fluoview software. Fluorescence excitation
and bleaching was performed with a pulsed Ti:sapphire laser at 890 nm
(Spectra Physics MaiTai HP DeepSee). A small circular region was bleached
for 50 ms with the tornado scanning option of the main scanner of the system.
The high-speed scanning mode was used at 8 frames/s to record 10 frames
before the bleaching event and to monitor fluorescence recovery for 100
frames afterwards.
Statistical Analysis
Frequency distribution analysis and the nonparametric Wilcoxon Mann-Whit-
ney Test were performed on data with GraphPad Prism version 5.00 for
Windows, GraphPad Software, San Diego, CA (http://www.graphpad.com).
Instrument
Single-molecule fluorescence microscopy was performed with an Olympus
TIRFM system based on an inverted microscope (Olympus IX81), 150 3 NA
1.45 TIRFM objective (Olympus), motorized filter wheel (Olympus), sensitive
EMCCD camera (Cascade II, Photometrics), and real time data acquisition
(Olympus, CellR). Three laser lines (488 nm, 561 nm, and 635 nm) can be
used simultaneously while TIRF illumination is individually adjusted with three
separate TIRFM illumination combiners (Olympus). Simultaneous two-channel
recording was accomplished by mounting an image splitter (Optosplit II, Cairn
Research, Faversham, UK) and a second EMCCD camera (Quant EM 512SC,
Photometrics) on the bottom port. Image acquisition for the second camera
was recorded with Image-Pro Plus (Media Cybernetics). Image registrationwas achieved by measuring the position of fluorescent microspheres (Tetra-
Spek 0.1 mm, Invitrogen).
Image Processing
Dual View TIRFM channels of actin or ezrin and BCR were split with the Cairn
Image Splitter plugin of ImageJ (NIH, http://rsb.info.nih.gov.ij). Actin or Ezrin
images for movie overlays were then time averaged (5 frames) (http://
valelab.ucsf.edu/nico/IJplugins/), background subtracted (rolling ball size
15), and Gaussian filtered (1), all via ImageJ.
Single-Molecule Detection
For single-molecule imaging, an area of approximately 2300 mm2 was illumi-
nated by 3.5 mW laser power resulting in a power density of approximately
150 W/cm2 out of the objective. From the size, intensity, and single-step or
multistep photobleaching (Figure S1), we conclude that we are able to image
single BCR molecules labeled with one or two fluorophores. Individual fluoro-
phores show characteristic intensity fluctuations on the millisecond to second
time scale (blinking) when the fluorophore converts to a transient dark state
(data not shown; Aitken et al., 2008). Frame rates of 20 frames/s were used
to record image sequences of 200 frames. The signal to noise ratio, defined
as the peak intensity after background subtraction divided by the standard
deviation of the background fluctuations, was measured on one experimental
data set as 7.2 ± 0.6 (n = 10) (Bobroff, 1986).
SUPPLEMENTAL INFORMATION
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